CD4 and Opportunistic infection: The short period of time to achieve undetectability and CD4 lymphocyte count >200/μL (less than two months in both cases) should be noted, leading patients to a clear decrease in the possibility of opportunistic infections in the first six months after starting antiretroviral therapy [16].